Evidence map›Paper›PMID 29449625›Full record

ArticleCell death & disease2018

Toll-like receptor 4 modulation influences human neural stem cell proliferation and differentiation.

Chiara Grasselli, Daniela Ferrari, Cristina Zalfa, Matias Soncini, Gianluigi Mazzoccoli, Fabio A Facchini, Laura Marongiu, Francesca Granucci, Massimiliano Copetti, Angelo Luigi Vescovi and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. TLR5 Supports Development of Placental Labyrinthine Zone in Mice.Frontiers in cell and developmental biology · 2021
    Article
  14. Strategies for Biomaterial-Based Spinal Cord Injury RepairFrontiers in bioengineering and biotechnology · 2021
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. GABAPsychopharmacology · 2019
    Review
  20. Effect of alternanRSC advances · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Chiara GrasselliDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, MI, Italy.
Daniela FerrariDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, MI, Italy.
Cristina ZalfaDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, MI, Italy.
Matias SonciniDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, MI, Italy.ORCID 0000-0001-5973-7515
Gianluigi MazzoccoliDepartment of Medical Sciences, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, FG, Italy.ORCID 0000-0003-3535-7635
Fabio A FacchiniDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, MI, Italy.ORCID 0000-0002-4339-5845
Laura MarongiuDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, MI, Italy.
Francesca GranucciDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, MI, Italy.
Massimiliano CopettiUnit of Biostatistics, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, FG, Italy.
Angelo Luigi VescoviDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, MI, Italy.
Francesco PeriDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, MI, Italy. francesco.peri@unimib.it.
Lidia De FilippisDepartment of Regenerative Medicine, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, FG, Italy. l.defilippis@operapadrepio.it.
University of Milano-Bicocca · ITCasa Sollievo della Sofferenza · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toll-like receptor 4 (TLR4) activation is pivotal to innate immunity and has been shown to regulate proliferation and differentiation of human neural stem cells (hNSCs) in vivo. Here we study the role of TLR4 in regulating hNSC derived from the human telencephalic-diencephalic area of the fetal brain and cultured in vitro as neurospheres in compliance with Good Manifacture Procedures (GMP) guidelines. Similar batches have been used in recent clinical trials in ALS patients. We found that TLR2 and 4 are expressed in hNSCs as well as CD14 and MD-2 co-receptors, and TLR4 expression is downregulated upon differentiation. Activation of TLR4 signaling by lipopolysaccharide (LPS) has a positive effect on proliferation and/or survival while the inverse is observed with TLR4 inhibition by a synthetic antagonist. TLR4 activation promotes neuronal and oligodendrocyte differentiation and/or survival while TLR4 inhibition leads to increased apoptosis. Consistently, endogenous expression of TLR4 is retained by hNSC surviving after transplantation in ALS rats or immunocompromised mice, thus irrespectively of the neuroinflammatory environment. The characterization of downstream signaling of TLR4 in hNSCs has suggested some activation of the inflammasome pathway. This study suggests TLR4 signaling as essential for hNSC self-renewal and as a novel target for the study of neurogenetic mechanisms.

Indexed as

Cell ProliferationNeurogenesisAmyotrophic Lateral SclerosisAnimalsApoptosisCell LineDisease Models, AnimalHumansImmunocompromised HostMaleMice, NudeNeural Stem CellsRats, TransgenicSignal TransductionSpheroids, CellularSuperoxide Dismutase-1Superoxide Dismutase-1TLR4 protein, humanToll-Like Receptor 4

Identifiers

PMID29449625
PMCPMC5833460
OpenAlexW2788081407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.